Rationale Agonist-based pharmacologic intervention is an accepted approach in treatment
of opioid and tobacco use disorders. Objectives We conducted a systematic review and …

Diverse intellectual functions including memory are some important aspects of cognition.
Dopamine is a neurotransmitter of the catecholamine family, which contributes to the …

Currently, there are no approved pharmacotherapies for addiction to cocaine and other
psychostimulant drugs. Several studies have proposed that cannabidiol (CBD) could be a …

Achieving abstinence from drugs is a long journey and can be particularly challenging in the
case of methamphetamine, which has a higher relapse rate than other drugs. Therefore, real …

Globally, millions of people suffer from various substance use disorders (SUD), including
mono-and polydrug use of opioids and methamphetamine. Brain regions such as the …

Background Methamphetamine's effects on brain function have been associated with
cognitive deficits, which have a negative impact on clinical outcomes. However, it remains …

Importance Impulsivity during periods of abstinence is a critical symptom of patients who use
methamphetamine (MA). Objective To evaluate changes in impulse inhibition elicited by …

Background Deficits in executive function are common in methamphetamine use disorder
(MUD), likely contributing to difficulties in sustained treatment success. Cognitive …

Background Dysfunction in brain network dynamics has been found to correlate with many
psychiatric disorders. However, there is limited research regarding resting …

Methamphetamine use disorder (MUD) as a major public health risk is associated with
dysfunctional neural feedback processing. Although dysfunctional feedback processing in …